Durable responses with checkpoint inhibitor Larry H. Bernstein, MD, FCAP, Curator LPBI   Immunotherapy Active in ‘Universally Lethal’ Glioblastoma ACTIVATE CME    by Kristin Jenkins  Contributing Writer, MedPage Today http://www.medpagetoday.com/HematologyOncology/BrainCancer/57641   Two pediatric siblings with recurrent multifocal glioblastoma multiforme (GBM) refractory to current standard therapies exhibited “remarkable and durable” responses to immune checkpoint inhibition with single-agent … Continue reading Durable responses with checkpoint inhibitor